第25届国际外科、消化道和肿瘤科医师协会会议

　　We are truly delighted to invite you to participate at the IASGO’s 25th Anniversary World Congress that will take place in conjunction with the Chinese Surgical Week in Fuzhou, China on September 4-6, 2015.

　　

　　We feel privileged and honored that our World Congress is hosted by the Chinese Society of Surgery, and, on this occasion, we would like to express our warmest thanks and sincere appreciation to Professor Yupei Zhao, and to the members of the Executive Board of the Chinese Society of Surgery, for their support and dedication.

　　

　　The late Professor Nikolaos Lygidakis, MD, PhD, FACS, FRCST(H), FJSS(H), the founder of the IASGO, has strongly promoted to organization of this landmark event in China. A passionate believer in the globalization of best medical knowledge and practices, he has devoted himself to spread of multidisciplinary approaches to treatment of deadly diseases, beyond any frontier and for all people. With his seemingly limitless positive energy and optimism, and with his unique vision, Professor Lygidakis has played a key role in the promotion of World Congress as well as in the creation of Advanced Post Graduate Courses all around the world, for improvement of standards of medical care, globalization of current medical knowledge, and pioneering and innovative steps for further progress of our knowledge. We are proud to be able to carry on the legacy of Professor Lygidakis at the IASGO.

　　

　　This World Congress will be a unique event for several reasons. We expect participation of several thousands experts from more than 70 countries. The scientific program includes world-recognized leaders in their fields who will discuss the latest developments in the field of diagnosis and management of abdominal malignancies. Standard practices as well as the latest developments in the fields of surgical oncology, advanced open surgery, minimally invasive surgery, medical and radiation oncology, and translational medicine will be presented by experts from all over the world, and the meeting point between different disciplines will be reached, in order to define the status of tailored management for all the patients suffering from abdominal malignancies and systemic diseases. The purpose is twofold: discuss the state-of-the-art as well the expected developments of the near future； and engage surgeons, gastroeneterologists and oncologists in active discussion on new concepts and new principles regarding multidisciplinary strategies for the management of these diseases.

　　

　　It goes beyond saying that besides the scientific program, the social program will be unique. Fuzhou is a city in south China, famous for its sea views, mountains and historical sites. This beautiful city just one hour's flight away from Shanghai. We are going to enjoy fantastic Chinese hospitality, and the treasure of Chinese culture.

　　征文范围及要求：     

　　Main Scientific Topics

　　

　　01New Frontiers in the management of liver malignancies: Present possibilities, and the future prospective of surgery (open, laparoscopic, robotic), mini-invasive radiology (ablation, chemoembolization), medical oncology (cancer research, molecular targeted therapies, translational oncology)02 New Developments in Surgical Techniques for Liver Surgery-Liver Transplantation: Present and Future (extended liver resection combined with regional vascular resection, IVC, portal vein-hepatic artery, and new techniques of reconstruction using venous grafts or cryo-preserved grafts)03New technical developments in the field of living donor liver transplantation: Present and future04The role of mini-invasive radiology for the management of HCC, using new drugs: early results from the clinical application of chemoembolization for the management of HCC using Primovist: Present and future05 New developments in the field of pancreatic surgery (open, laparoscopic, robotic)06New developments in the field of medical oncology and molecular targeted therapies for pancreatic cancer: the value of neo-adjuvant and adjuvant therapies 07 New technical developments in surgical techniques for pancreatic cancer (extensive regional vascular resections: when and how) 08Organ-preserving pancreatic surgery09 Newest developments in the management of gastroesophageal cancer: the role of surgery (open, laparoscopic, robotic), of mini-invasive endoscopy, and of radiology10 New technical developments in the surgery of gastroesophageal cancer11 New developments in the field of Medical Oncology and cancer research for gastroesophageal malignancies12Bariatric/metabolic surgery for Type II diabetes in Asia: the role of gastric bypass, mini gastric bypass and ileal interposition: when and how to do it13 New developments in the management of colorectal cancer: new developments in the technical possibilities of sphincter preservation； resection for colorectal liver metastasis； multidisciplinary approach to advanced colorectal cancer； the role of neo-adjuvant and adjuvant chemoradiotherapy14The role of anti-angiogenetic drugs in the management of primary and metastatic colorectal cancer15The role of HIPEC for advanced colorectal cancer16 The role of HIPEC for peritoneal carcinomatosis, secondary to colorectal/pancreatic/gastroesophageal/ovarian malignancies 17The role of HIPEC combined with cytoreductive surgery for the management of peritoneal carcinomatosis secondary to ovarian/colorectal/pancreatic/gastroesophageal malignancies